No Data
No Data
Express News | X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective
Express News | Cantor Fitzgerald Reiterates Overweight on X4 Pharmaceuticals, Maintains $5 Price Target
X4 Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/31/2024 399.35% Cantor Fitzgerald $5 → $5 Reiterates Overweight → Overweight 04/30/2024 399.35% HC Wain
X4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
BOSTON, May 13, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that management
X4 Pharma Gains on New $125 Financing
No Data
HBHD : I am holding this stock for at least two years
BeeDeeVee712 HBHD: Same, I think that's a good call (yada che che yada!!!)
Jaguar8OP BeeDeeVee712: So don’t forget June 27. Hoping to have a promising clinical trial results.
BeeDeeVee712 : I was kinda assuming positive trial results the 27th were a given for it to be a long-term hold for me, I can’t speak for anyone else, but yes, I’m pumped for the results the 27th!! WOOT WOOTTT LETS GOOOOOO!!!
Jaguar8OP BeeDeeVee712: Yes I have the same thought. It’s like more than 3 weeks more. But I think it’s a strategy. The stock will get uptick probably a week before results. This will be like buy the rumors, sell the news type. So put price alerts on this stock